Intended for healthcare professionals

Editorials

New Zealand’s bold new tobacco control programme

BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o62 (Published 18 January 2022) Cite this as: BMJ 2022;376:o62
  1. Sanjay Agrawal, consultant in respiratory and intensive care medicine1,
  2. John Britton, emeritus professor of epidemiology2
  1. 1University Hospitals of Leicester NHS Trust, Leicester, UK
  2. 2University of Nottingham, Nottingham, UK
  1. Correspondence to: S Agrawal sanjay.agrawal{at}uhl-tr.nhs.uk

Ground breaking legislation targets sales of this uniquely lethal consumer product

In December 2021, the New Zealand Ministry of Health published a new tobacco control programme with the goal of reducing smoking prevalence to less than 5% by 2025.1 The prevalence of current smoking in New Zealand is 10.9%, and the rate of fall suggests that this is a realistic aim.2 However, the plan goes much further: it seeks, by 2025 to reach 5% or less in all New Zealand population groups. Among the Māori population, for example, this means reducing the proportion who smoke from one in four to one in 20 in just four years.2 This is an ambitious programme. Will it work?

Tobacco control policy is already well developed in New Zealand, and the plan proposes to work in partnership with Māori leadership …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription